BLC — Bastide le Confort Medical SA Income Statement
0.000.00%
Last trade - 00:00
- €111.30m
- €513.20m
- €508.03m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 336 | 383 | 444 | 468 | 508 |
Cost of Revenue | |||||
Gross Profit | 161 | 188 | 210 | 232 | 253 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 317 | 354 | 416 | 436 | 471 |
Operating Profit | 19 | 29.2 | 28.3 | 32.5 | 36.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.3 | 20.3 | 20.2 | 21 | 22.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.38 | 12.6 | 14.3 | 15.1 | 16.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4.57 | 11.6 | 13.5 | 13.7 | 12 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.57 | 11.6 | 13.5 | 13.7 | 12 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.29 | 1.82 | 2.17 | 2.28 | 2.32 |
Dividends per Share |